Although accumulating evidence indicates the roles and clinical significance of ESRP1 and its alternative splicing targets in tumor progression and metastasis, ESRP1-regulated alternative splicing in gastric cancer has not yet been thoroughly studied. The gene discussed is ESRP1; the disease is neoplasm.